Post-approval studies (Phase 4)Ended earlyNCT01890694
What this trial is testing
Tolvaptan to Reduce Length of Stay in Hospitalized Patients With Cirrhosis and Hyponatremia
Who this might be right for
Hyponatremia
NYU Langone Health 2
Showing 7 of 7 results